V. Voelter

Discipline

Psychologie (1)

Type de document

Articles (8)

Co-auteur

Date

Source

Mot-clé

Melanoma (7) Patients (6) Patients (6) Treatment (5) Chemotherapy (5) Metastasis (5) Human beings (5) Chemotherapy (5) procès (4) Older people (4) maladie (3) adulte (3) survie (3) Development (3) Control (3) Methods (3) T cells (3) Survival (3) Population (3) Liver (3) Cells (3) Methods (3) Population (3) adulte (3) maladie (3) administration (2) puits (2) temps (durée) (2) thérapie (2) peau (2)

Documents écrit par V. Voelter (8) | parle de V. Voelter (0)

MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial.
E. Romano et al. (2014)
18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
V. Orcurto et al. (2012)
Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.
V. Voelter et al. (2008)
Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor.
V. Voelter et al. (2008)
In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration.
L. Derré et al. (2007)
Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens.
P. Baumgaertner et al. (2006)
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.
S. Peters et al. (2006)
CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.
V. Voelter et al. (2006)